FT Global 500 2015 by sector

FT Global 500 2015

Market value by sector
Total Market
Value ($m)

Sector

Percent of
pharma &
biotech

Number of
Avg Market Value
companies Market value ($m) ($m) p/ Company

Banks

71

4,884,560.6

68797

Pharmaceuticals & biotechnology

30

3,016,060.5

100535

Oil & gas producers

31

2,467,372.5

79593

Software & computer services

16

1,842,175.2

115136

Technology hardware & equipment

19

1,776,050.4

93476

General retailers

16

1,267,366.2

79210

Financial services

28

1,242,061.9

44359

Automobiles & parts

17

1,092,660.3

64274

Nonlife insurance

15

941,078.0

62739

Mobile telecommunications

15

938,888.8

62593

Beverages

10

904,484.1

90448

Media

16

895,797.8

55987

General industrials

11

829,227.4

75384

Chemicals

16

790,557.2

49410

Fixed line telecommunications

11

789,928.3

71812

Personal goods

13

713,951.7

54919

Travel & leisure

17

686,093.9

40358

Health care equipment & services

14

668,600.4

47757

Life insurance

10

640,678.9

64068

548,470.8

68559

10

522,003.4

52200

Food producers
Aerospace & defence
Tobacco

495,611.1

70802

Industrial transportation

10

470,682.2

47068

Industrial engineering

13

455,772.6

35059

Food & drug retailers

412,189.1

51524

11

393,990.7

35817

Oil equipment & services

371,380.0

Mining

344,891.9

68978

Household goods & home construction

282,936.0

141468

Leisure goods

277,407.0

92469

Real estate investment trusts

270,910.1

33864

Electronic & electrical equipment

253,850.2

36264

Construction & materials

237,741.6

33963

Gas, water & multiutilities

207,272.1

41454

Real estate investment & services

204,438.3

34073

Support services

184,258.7

36852

Alternative energy

37,504.2

37504

Industrial metals & mining

28,310.2

28310

Electricity

32,387,213.8

9.3%

Market value ($m) by sector

Banks
Pharmaceu.cals &
biotechnology
Oil & gas producers
So;ware & computer
services
Technology hardware &
equipment
General retailers

53054

FT Global 500 2015 by sector

Market value
Total Assets
$m
Turnover $m Net Income $m $m

Price $

Dividen
d yield
(%)

Country

PE ratio

Global rank 2015 Global rank 2014 Company

Employ
ees

Sector

Sector
rank

Market values & prices at 31 Mar 15

Year end

Pharmaceuticals & biotechnology

1

10

16

20

36

6 Johnson & Johnson

US

279,723.9

74,331.0

16,323.0

127,723.0

126,500

100.6

17.6

2.7 28-Dec-14

14 Novartis

Switzerland

267,897.0

49,550.7

9,432.7

117,393.4

9 Roche

Switzerland

237,747.6

47,748.7

9,388.4

73,251.8

133,413

99.0

25.4

2.6 31-Dec-14

88,509

276.0

25.0

19 Pfizer

US

213,621.9

49,605.0

9,134.0

33 Merck

US

163,139.3

42,237.0

11,920.0

2.9 31-Dec-14

167,730.0

78,300

34.8

24.7

3.0 31-Dec-14

98,335.0

70,000

57.5

14.1

43

60 Gilead Sciences

US

145,532.9

24,890.0

3.1 31-Dec-14

12,101.0

34,428.0

7,000

98.1

13.4

47

40 Sanofi

France

130,260.0

52

80 Amgen

US

121,303.9

31-Dec-14

41,244.3

5,308.3

111,888.8

113,496

98.7

24.4

3.5 31-Dec-14

20,063.0

5,158.0

69,009.0

17,900

159.9

23.9

1.5 31-Dec-14

285 Actavis

54

US

120,536.1

13,062.3

-1,630.5

52,421.7

21,600

297.6

10

64

68 Novo Nordisk

Denmark

112,977.6

14,428.3

4,302.4

11,643.1

40,957

53.5

32.6

1.5 31-Dec-14

11

66

45 GlaxoSmithKline

UK

111,649.6

35,834.8

4,292.8

59,132.3

98,702

23.0

25.8

5.4 31-Dec-14

12

68

93 Bristol Myers Squibb

US

107,500.1

15,879.0

2,004.0

32,834.0

25,000

64.5

53.8

2.2 31-Dec-14

13

77

US

99,063.5

9,703.3

2,934.8

14,316.6

7,550

422.2

34.1

31-Dec-14

14

84

97 Abbvie

US

93,204.1

19,960.0

1,774.0

27,547.0

26,000

58.5

53.2

2.8 31-Dec-14

86

166 Celgene

US

15

115 Biogen Idec

31-Dec-14

92,292.0

7,670.4

1,999.9

17,340.1

6,012

115.3

48.2

31-Dec-14

16

95

UK

86,763.1

24,695.5

1,166.9

57,375.9

57,500

68.7

73.8

4.0 31-Dec-14

17

102

132 Eli Lilly

US

80,714.4

19,615.6

2,390.5

37,178.2

39,135

72.7

32.6

2.7 31-Dec-14

18

127

157 Abbott Laboratories

US

69,910.9

20,247.0

2,284.0

39,725.0

77,000

46.3

30.9

1.9 31-Dec-14

19

132

226 Valeant Pharmaceuticals International Canada

67,339.0

7,878.5

870.9

26,298.9

16,800

197.6

75.7

31-Dec-14

20

156

202 Teva Pharmaceutical

Israel

60,038.5

18,664.0

2,812.7

46,420.0

43,009

62.8

19.0

2.0 31-Dec-14

21

209

375 Shire

UK

47,009.3

5,699.1

3,222.9

13,520.0

5,016

79.6

14.5

0.3 31-Dec-14

22

217

364 Regeneron Pharmaceuticals

US

45,008.9

2,819.6

348.1

3,605.0

2,925

451.5

23

272

271 Takeda Pharmaceutical

Japan

39,511.9

16,392.6

1,033.5

42,255.4

31,225

50.0

38.2

3.5

24

300

408 Astellas Pharma

Japan

37,074.9

11,045.7

880.6

15,577.4

17,649

16.4

42.1

1.6

25

314

354 Alexion Pharmaceuticals

US

35,032.3

2,233.7

656.9

4,167.0

2,273

173.3

53.2

26

326

India

33,886.6

2,679.0

523.4

4,695.5

14,000

16.4

65.4

0.2

27

346

Australia

33,081.3

5,702.4

1,349.1

5,978.6

12,196

70.4

25.2

1.7

28

407

Mylan

US

28,985.9

7,719.6

929.4

15,803.2

25,000

59.4

23.8

29

416

Vertex Pharmaceuticals

US

28,559.2

580.4

-738.6

2,334.7

1,830

118.0

30

457

Illumina

US

26,695.0

1,861.4

353.4

3,289.8

3,700

185.6

98 AstraZeneca

Sun Pharmaceutical Industries

341 CSL

Page 1

31-Dec-14
31-Mar-14
31-Mar-14
31-Dec-14
31-Mar-14
30-Jun-14
31-Dec-14
31-Dec-14
78.3

28-Dec-14